Müller-Deile Janina, Schiffer Mario
Department of Nephrology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
Pflugers Arch. 2017 Aug;469(7-8):1007-1015. doi: 10.1007/s00424-017-1993-z. Epub 2017 May 16.
The central role of podocytes in glomerular diseases makes this cell type an interesting diagnostic tool as well as a therapeutic target. In this review, we discuss the current literature on the use of podocytes and podocyte-specific markers as non-invasive diagnostic tools in different glomerulopathies. Furthermore, we highlight the direct effects of drugs currently used to treat primary glomerular diseases and describe their direct cellular effects on podocytes. A new therapeutic potential is seen in drugs targeting the podocytic actin cytoskeleton which is essential for podocyte foot process structure and function. Incubation of cultured human podocyte cell lines with sera from patients with active glomerular diseases is currently also used to identify novel circulating factors with pathophysiological relevance for the glomerular filtration barrier. In addition, treatment of detached urinary podocytes from patients with substances that restore their cytoskeleton might serve as a novel personalized tool to estimate their potential for podocyte recovery ex vivo.
足细胞在肾小球疾病中的核心作用使其成为一种有趣的诊断工具以及治疗靶点。在本综述中,我们讨论了有关将足细胞和足细胞特异性标志物用作不同肾小球病无创诊断工具的当前文献。此外,我们强调了目前用于治疗原发性肾小球疾病的药物的直接作用,并描述了它们对足细胞的直接细胞效应。在靶向足细胞肌动蛋白细胞骨架的药物中发现了新的治疗潜力,该细胞骨架对足细胞足突结构和功能至关重要。目前也采用将患有活动性肾小球疾病患者的血清与培养的人足细胞系进行孵育的方法,来鉴定与肾小球滤过屏障具有病理生理相关性的新型循环因子。此外,用能恢复其细胞骨架的物质处理来自患者的脱落尿足细胞,可能作为一种新型个性化工具,用于在体外评估其足细胞恢复的潜力。